THE AGE-DEFYING POWERHOUSE As skin ages, its rejuvenative processes perform less efficiently. One key reason is a lack of cellular communication, which can accelerate the loss of collagen and impair skin elasticity. At SkinMedica®, we are the industry leader in skin rejuvenation because we target one of the primary causes of visible skin aging—diminishing growth factors.
We took it to the next level with TNS® Advanced+ Serum—the only growth factor product proven to address sagging skin. It significantly smooths the appearance of coarse wrinkles and fine lines, with results in as little as 2 weeks and progressive results over 24 weeks. 1
IN CLINICAL STUDIES 1 :
6Y
+
6 YEARS YOUNGER A third-party, validated psychometric scale revealed that patients felt they looked up to 6 years younger after 12 weeks.
APPEARANCE OF SAGGING SKIN Significant improvements in the appearance of sagging skin after 8 weeks.
PROGRESSIVE IMPROVEMENT Subjects felt increasingly more satisfied with continued use measured over 24 weeks.
PATIENTS SAW DRAMATIC RESULTS VISIBLE RESULTS KEEP GETTING BETTER, WITH PROGRESSIVE IMPROVEMENT. 1
IMPROVEMENTS AT WEEK 2
IMPROVEMENTS AT WEEK 24
+ BASELINE
+ 2 WEEKS
+ BASELINE
+ 24 WEEKS
Female, age 60, Fitzpatrick Skin Type II. Unretouched photos, taken in standard lighting. Individual results may vary.
Female, age 68, Fitzpatrick Skin Type II. Unretouched photos, taken in standard lighting. Individual results may vary.
With TNS® Advanced+ Serum, SkinMedica® goes further than ever in addressing the visible signs of skin aging.
VISIT SKINMEDICA.COM TO LEARN MORE.
1. Data on file at SkinMedica®. The SkinMedica® product described here is intended to meet the FDA’s definition of a cosmetic product, an article applied to the human body to cleanse, beautify, promote attractiveness, and alter appearances. This SkinMedica® product is not intended to be a drug product that diagnoses, treats, cures, or prevents any disease or condition. This product has not been approved by the FDA, and the statements here have not been evaluated by the FDA.
© 2022 AbbVie. All rights reserved. SkinMedica® is a trademark of Allergan, Inc., an AbbVie company. AllerganAesthetics.com SkinMedica.com 154350 04/22 016626
Made with FlippingBook Digital Proposal Creator